Navigation Links
Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
Date:1/29/2009

);">
  • Educational information to help patients better understand GIST-- its causes, diagnosis, and management--and the critical importance of adherence to GIST treatment
  • Important questions to ask of the healthcare team so patients/caregivers can maximize these interactions and play an active role in GIST treatment
  • Comprehensive glossary of GIST terms-to-know so patients/caregivers are well-informed
  • Reimbursement support services to help ensure patients get the treatments they need
  • Email, telephone, and direct mail support services to respond to additional inquiries of patients/caregivers/loved ones

  • Novartis Oncology is committed to develop and deliver a comprehensive treatment strategy to KIT+GIST patients through GIST Alliance.

    GIST Alliance is available at no cost to patients, caregivers, or their treating physicians. Enrollment and/or participation in GIST Alliance are voluntary.

    For more information visit the GIST Alliance Web site at: GISTAlliance.com.

    1. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol Mech Dis. 2008;3:557-586.

    2. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007;5(Suppl2):S1-S29.

    3. Griffin JM, St Amand M, Demetri GD. Nursing implication of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors. Clin J Oncol Nurs. 2005;9(2):161-169.

    ###

    Read the full story at http://www.prweb.com/releases/NovartisGISTPatient/01292009/prweb1930294.htm.


    '/>"/>
    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    Page: 1 2

    Related medicine news :

    1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
    2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
    6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
    7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
    8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
    9. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
    10. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
    11. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... get more fruits and vegetables at school than they do ... is true for students from wealthier families. These findings ... a healthy boost to poor students, diets, according to the ... students all ate a similar amount of fruits and vegetables ... recently in the journal Preventive Medicine . ...
    (Date:12/17/2014)... Alan Mozes HealthDay Reporter ... party season fast approaching, a new study reveals that states ... have fewer drunk drivers on their roads. The finding ... are better able to deter inebriated revelers from getting behind ... laws are being passed regarding drinking and driving," said study ...
    (Date:12/17/2014)... Kathleen Doheny HealthDay Reporter , ... is rampant in America, and work commitment is a big ... 1 sleep killer," said Dr. Mathias Basner, an assistant professor ... Pennsylvania Perelman School of Medicine. A time-use survey of ... work is the main activity exchanged for sleep. Short sleepers ...
    (Date:12/15/2014)... Cancer researchers have just published an important new report ... pleural mesothelioma. Surviving Mesothelioma has just posted an article ... to read it now. , Doctors at Harvard, ... York’s Langone Medical Center performed complete genetic analyses on ... effort to pinpoint the genes that are most likely ...
    (Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ... on a new study providing evidence on the impact ... of children. , Sufficient enough evidence already exists showing ... or juice drinks, with the onset of tooth decay. ... drinks listed as 100% fruit juice, meaning it is ...
    Breaking Medicine News(10 mins):Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
    ... ... lifetime teeth bleaching services to new patients , ... Los Angeles (PRWEB) February 22, 2010 -- Leading cosmetic dentist in Los ... Life services. New patients who visit Dr. Galina for an exam, X-rays and cleaning appointment ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... Researchers at the Sahlgrenska Academy at the University of ... to reveal the different genetic patterns of neuroblastoma, an ... to significant advances in the treatment of this malignant ... is being published in the respected scientific journal, ...
    ... she has a genetic mutation on a gene known as ... could be as high as 84 percent by age seventy, ... Compounding her risk was the fact that her mother had ... consultation, Joi made the difficult decision of undergoing prophylactic bilateral ...
    ... ... released its new version of the Healthcare SafetyZone® Portal. Portal 2.0. , ... Chicago, IL (PRWEB) February 22, ... safety software and consulting services, announced today that it has launched its new 2.0 ...
    Cached Medicine News:Health News:LA Dentist, Dr. Katherine Galina, Offers Free Bleaching for Life 2Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 2Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 3Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 4Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 5Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 6Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 2Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 3Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 4Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 5Health News:New DNA technique leads to a breakthrough in child cancer research 2Health News:How to make the best decisions when at high risk for breast or ovarian cancer 2Health News:How to make the best decisions when at high risk for breast or ovarian cancer 3Health News:Clarity Group, Inc. Announces Launch of Portal 2.0, the Next Generation of the Healthcare SafetyZone Portal 2Health News:Clarity Group, Inc. Announces Launch of Portal 2.0, the Next Generation of the Healthcare SafetyZone Portal 3
    (Date:12/15/2014)... , December 15, 2014 ... drugs for aggressive drug resistant cancers, today announces that ... a private placing from new and existing investors. ... to support the development of its pipeline of innovative ... for its lead drug candidate, BGB324, a first-in-class selective ...
    (Date:12/15/2014)... Investor-Edge has initiated coverage on the ... Lilly and Company (NYSE: LLY ), Nektar Therapeutics ... ), and Novartis AG (NYSE: NVS ). Free ... http://investor-edge.com/register . On Friday, December 12, 2014, the ... Industrial Average lost 1.79%, to finish the day at 17,280.83, ...
    (Date:12/15/2014)... and BOSTON , December 15, 2014 ... structure-guided drug discovery and development company, is pleased to ... the United States relating to its ... in the US significantly strengthens the global patent estate ... markets. The suite of patents recently granted ...
    Breaking Medicine Technology:BerGenBio Completes NOK90 Million Fundraising 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
    ... best policy , , ROCHESTER, ... the use of the drug therapy etanercept ineffective in treating alcoholic ... of alcohol. The results of the study are published in the ... , VIDEO ALERT: Additional audio and ...
    ... 9 at 11:00 am ET to Discuss Phase 2 Study ... SOUTH SAN FRANCISCO, Calif., Dec. 1 ... biopharmaceutical company focused on the development and commercialization of new ... voreloxin in acute myeloid leukemia (AML) will be presented during ...
    Cached Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: